I earned my PhD at the University of Bergen on organoid models and novel biomarkers for improved treatment of endometrial cancer. I am currently a postdoctoral fellow in the Bergen Gynecological Research Group, where my main focus is to study drug resistance and identify new treatment strategies for endometrial cancer patients. Currently, I am working on a study that applies advanced functional genomics to identify genes responsible for carboplatin resistance. This new knowledge will be used to find novel treatments for chemotherapy resistant endometrial cancers.

Vitenskapelig artikkel

• Hjelmeland, Marta Espevold; Lien, Hilde Eide; Berg, Hege Fredriksen et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (ekstern lenke)
• Espedal, Heidi; Fasmer, Kristine Eldevik; Berg, Hege Fredriksen et al. (2024). MRI radiomics captures early treatment response in patient-derived organoid endometrial cancer mouse models. (ekstern lenke)
• Halle, Mari Kyllesø; Hodneland, Erlend; Wagner-Larsen, Kari Strøno et al. (2024). Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer. (ekstern lenke)
• Krakstad, Camilla; Berg, Hege Fredriksen; Lindemann, Kristina Yvonne Kathe et al. (2024). Frequency of ERBB2-Low Expression in Endometrial Cancer. (ekstern lenke)
• van der Berg, Madeleine Charlotte; Berg, Hege Fredriksen; Stokowy, Tomasz et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (ekstern lenke)
• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (ekstern lenke)
• Berg, Hege Fredriksen; Engerud, Hilde Renate; Myrvold, Madeleine et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (ekstern lenke)
• Espedal, Heidi; Berg, Hege Fredriksen; Fonnes, Tina et al. (2021). Feasibility and utility of MRI and dynamic 18F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer. (ekstern lenke)
• Høivik, Erling Andre; Hodneland, Erlend; Dybvik, Julie Andrea et al. (2021). A radiogenomics application for prognostic profiling of endometrial cancer. (ekstern lenke)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (ekstern lenke)
• Fonnes, Tina; Strand, Elin; Fasmer, Kristine Eldevik et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (ekstern lenke)
• Engerud, Hilde Renate; Berg, Hege Fredriksen; Myrvold, Madeleine et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (ekstern lenke)
• Berg, Hege Fredriksen; Ju, Zhenlin; Myrvold, Madeleine et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (ekstern lenke)
• Forsse, David Erik; Berg, Hege Fredriksen; Bozickovic, Olivera et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (ekstern lenke)
• Engerud, Hilde Renate; Hope, Kirsten Øvergaard; Berg, Hege Fredriksen et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (ekstern lenke)
• Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik; Konings, Gonda F et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (ekstern lenke)
• Fonnes, Tina; Berg, Hege Fredriksen; Onyango, Therese Bredholt et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (ekstern lenke)
• Halle, Mari Kyllesø; Tangen, Ingvild Løberg; Berg, Hege Fredriksen et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (ekstern lenke)

Errata

• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (ekstern lenke)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin